Ionis Pharmaceuticals inked a collaboration deal with Metagenomi with the goal of adding DNA editing to its RNA-targeted technologies focused on up to four genetic targets.
https://www.pharmalive.com/wp-content/uploads/2021/12/Ionis-and-AstraZeneca-Team-Up-on-Antisense-Drug-for-ATTR-BioSpace-12-7-21.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-11-14 09:00:412022-11-14 10:06:08Ionis partners with Metagenomi to add DNA editing to its toolbox
